HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central core myopathy with RYR1 mutation masks 5q spinal muscular atrophy.

Abstract
We report the case of a male who presented in infancy with motor delay and muscle weakness. Typical muscle biopsy features and heterozygous RYR1 mutation confirmed a diagnosis of central core disease. Family studies showed this to be a de-novo mutation. Some years later, his two older teenage brothers presented with proximal muscle weakness. Neurophysiology, muscle biopsy and DNA studies confirmed spinal muscular atrophy. Subsequent genetic studies in the index case also confirmed homozygous deletions of exon 7 and 8 in the SMN gene. Review of the original muscle biopsy showed classical features of central core disease with no evidence to suggest denervation, such that the diagnosis of spinal muscular atrophy could not have been suspected in the absence of the family history.
AuthorsR Pandey, S Chandratre, A Roberts, J S M Dwyer, C Sewry, R Quinlivan
JournalEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society (Eur J Paediatr Neurol) Vol. 15 Issue 1 Pg. 70-3 (Jan 2011) ISSN: 1532-2130 [Electronic] England
PMID20452790 (Publication Type: Case Reports, Journal Article)
Copyright© 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Ryanodine Receptor Calcium Release Channel
Topics
  • Adolescent
  • Biopsy
  • Child
  • Chromosomes, Human, Pair 5 (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Humans
  • Male
  • Mutation (genetics)
  • Myopathy, Central Core (genetics)
  • Ryanodine Receptor Calcium Release Channel (genetics)
  • Spinal Muscular Atrophies of Childhood (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: